Explore All Access
Check if your research matches the topics covered in Clinical Immunology Communications?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Clinical Immunology Communications : Impact Factor & More
eISSN: 2772-6134
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Clinical Immunology Communications Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 1750 |
| Publication Time | 10 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Clinical Immunology Communications ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Clinical Immunology Communications
Long-term follow-up of anti-IFN-α2 autoantibody levels in hospitalized individuals with COVID-19
- 1 Nov 2024
- Clinical Immunology Communications
Corrigendum to “Beneficial immune-regulatory effects of novel strains of Aureobasidium pullulansAFO-202 and N-163 produced beta glucans in Sprague Dawley rats” [Clinical Immunology Communications 1 (2021) 29–34]
- 1 Oct 2024
- Clinical Immunology Communications
CRISPR/Cas9-mediated RELA and RELC knockout in human regulatory T cells abrogates FOXP3 expression and suppressive function
- 1 Oct 2024
- Clinical Immunology Communications
Deficiency of interleukin-1 receptor antagonist: An updated review of the pathogenesis, clinical characteristics, and treatments
- 1 Sep 2024
- Clinical Immunology Communications
First report of Mycobacterium chimaera infection in a patient with chronic granulomatous disease
- 23 Jun 2024
- Clinical Immunology Communications
Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature
- 21 Jun 2024
- Clinical Immunology Communications
Long-term follow-up of anti-IFN-α2 autoantibody levels in hospitalized individuals with COVID-19
- 1 Nov 2024
- Clinical Immunology Communications
Corrigendum to “Beneficial immune-regulatory effects of novel strains of Aureobasidium pullulansAFO-202 and N-163 produced beta glucans in Sprague Dawley rats” [Clinical Immunology Communications 1 (2021) 29–34]
- 1 Oct 2024
- Clinical Immunology Communications
CRISPR/Cas9-mediated RELA and RELC knockout in human regulatory T cells abrogates FOXP3 expression and suppressive function
- 1 Oct 2024
- Clinical Immunology Communications
Deficiency of interleukin-1 receptor antagonist: An updated review of the pathogenesis, clinical characteristics, and treatments
- 1 Sep 2024
- Clinical Immunology Communications
First report of Mycobacterium chimaera infection in a patient with chronic granulomatous disease
- 23 Jun 2024
- Clinical Immunology Communications
Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature
- 21 Jun 2024
- Clinical Immunology Communications
FAQs on Clinical Immunology Communications
How many articles did Clinical Immunology Communications publish last year? 
In 2023, Clinical Immunology Communications publsihed 30 articles.
Who is the publisher of Clinical Immunology Communications?
Elsevier is the publisher of Clinical Immunology Communications.
